pullstraw5
About
Opposition profiles involving anaplastic lymphoma kinase tyrosine kinase inhibitors within innovative non-small-cell lung cancer: a multicenter study employing targeted next-generation sequencing.
Opposition profiles involving anaplastic lymphoma kinase tyrosine kinase inhibitors within innovative non-small-cell lung cancer: a multicenter study employing targeted next-generation sequencing.